| Name | Adsorbed Tetanus Vaccine |
| Classes |
Immunotherapeutic Agent Vaccine |
| Diseases |
Diphtheria Immunological Disorder Whooping Cough |
Bangla
EnglishAdsorbed Tetanus Vaccine
Tetanus Vaccine is a vaccine used for active immunization against tetanus. It belongs to the class of vaccines known as toxoid vaccines. The vaccine works by stimulating the immune system to produce antibodies against the tetanus toxin, providing protection against tetanus.
Adsorbed Tetanus Vaccine is a vaccine indicated for active immunization for the prevention of tetanus and diphtheria in persons 7 years of age and older.
- Each 0.5 mL dose should be administered intramuscularly.
- Primary immunization with Adsorbed Tetanus Vaccine consists of 3 doses. The first 2 doses are administered 2 months apart and the third dose is administered 6-8 months after the second dose.
- Adsorbed Tetanus Vaccine may be used for booster immunization against tetanus and diphtheria. Routine booster immunization against tetanus and diphtheria is recommended at 11-12 years of age and every 10 years thereafter.
- For post-exposure diphtheria prophylaxis and for management of a tetanus prone wound, a booster dose of Adsorbed Tetanus Vaccine may be administered if at least 5 years have elapsed since previous receipt of a diphtheria toxoid and tetanus toxoid containing vaccine.
Adverse reactions to Tetanus Vaccine may include:
- Pain, redness, or swelling at the injection site
- Low-grade fever
- Headache
- Fatigue
- Muscle aches
- Nausea
- Rarely, allergic reactions
- The tip caps of the prefilled syringes may contain natural rubber latex which may cause allergic reactions in latex sensitive individuals.
- More frequent administration of Adsorbed Tetanus Vaccine than described in Dosage and Administration may be associated with increased incidence and severity of adverse reactions.
- Persons who experienced an Arthus-type hypersensitivity reaction following a prior dose of a tetanus toxoid-containing vaccine should not receive Adsorbed Tetanus Vaccine more frequently than every 10 years, even for tetanus prophylaxis as part of wound management.
- Carefully consider benefits and risks before administering Adsorbed Tetanus Vaccine to persons with a history of Guillain-Barré syndrome within 6 weeks of a previous tetanus toxoid-containing vaccine.
- Procedures should be in place to prevent falling and injury and to manage syncope.
Contraindication
Tetanus Vaccine is contraindicated in individuals with a known hypersensitivity to any component of the vaccine or a previous history of severe allergic reactions to the vaccine.
None known.
None known.